3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Multiple Myeloma
107
Precursor Cell Lymphoblastic Leukemia-Lymphoma
38
Leukemia
23
Lymphoma
20
Recurrence
16
Burkitt Lymphoma
16
Lymphoma, Mantle-Cell
13
Neoplasms, Plasma Cell
11
Lymphoma, Non-Hodgkin
11
Waldenstrom Macroglobulinemia
9
Lymphoma, Follicular
9
Immunoglobulin Light-chain Amyloidosis
9
Hodgkin Disease
9
Breast Neoplasms
9
Vomiting
8
Neoplasms
8
Nausea
8
Lymphoma, B-Cell, Marginal Zone
8
Lymphoma, Large B-Cell, Diffuse
7
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
6
Lymphoma, T-Cell, Cutaneous
6
Leukemia, Lymphocytic, Chronic, B-Cell
6
Amyloidosis
6
Leukemia, Myeloid, Acute
5
Smoldering Multiple Myeloma
4
Sezary Syndrome
4
Mycosis Fungoides
4
Lymphoma, Large-Cell, Immunoblastic
4
Lung Neoplasms
4
Blast Crisis
4
Interventions
Gemcitabine
5
130-nm albumin-bound paclitaxel
5
Albumin-Bound Paclitaxel
4
napabucasin
3
Ocoxin
3
Irinotecan
3
Fluorouracil
3
Paclitaxel
2
Oxaliplatin
2
Nivolumab
2
Leucovorin
2
Cyclophosphamide
2
Capecitabine
2
Bevacizumab
2
trifluridine tipiracil drug combination
1
trametinib
1
pralsetinib
1
pembrolizumab
1
ozanimod
1
halofantrine
1
guadecitabine
1
ficlatuzumab
1
Ursodeoxycholic Acid
1
Sorafenib
1
Radiotherapy
1
Pemetrexed
1
Oviposition
1
Nadroparin
1
Lenalidomide
1
Imatinib Mesylate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Digestive System Diseases
×
Calcium Dobesilate
×
Clear all
NCT03723447
2021-02-17
TINGLE
Cedars-Sinai Medical Center
Phase 4
Completed
102 enrolled
9 charts